Authors:
CAUSSADE F
VIRONEODDOS A
DELCHAMBRE C
CAZES M
VERSIGNY A
CLOAREC A
Citation: F. Caussade et al., IN-VITRO PHARMACOLOGICAL CHARACTERIZATION OF UP-269-6, A NOVEL NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, Fundamental and clinical pharmacology, 9(2), 1995, pp. 119-128
Authors:
NICOLAI E
CURE G
GOYARD J
KIRCHNER M
TEULON JM
VERSIGNY A
CAZES M
VIRONEODDOS A
CAUSSADE F
CLOAREC A
Citation: E. Nicolai et al., SYNTHESIS AND ANGIOTENSIN-II RECEPTOR ANTAGONIST ACTIVITY OF C-LINKEDPYRIMIDINE-DERIVATIVES, European journal of medicinal chemistry, 30(5), 1995, pp. 365-375
Citation: M. Cazes et al., IN-VIVO PHARMACOLOGICAL CHARACTERIZATION OF UP-269-6, A NOVEL NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, European journal of pharmacology, 284(1-2), 1995, pp. 157-170
Authors:
NICOLAI E
CURE G
GOYARD J
KIRCHNER M
TEULON JM
VERSIGNY A
CAZES M
CAUSSADE F
VIRONEODDOS A
CLOAREC A
Citation: E. Nicolai et al., SYNTHESIS AND SAR STUDIES OF NOVEL TRIAZOLOPYRIMIDINE DERIVATIVES AS POTENT, ORALLY-ACTIVE ANGIOTENSIN-II RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 37(15), 1994, pp. 2371-2386
Authors:
NICOLAI E
CURE G
GOYARD J
KIRCHNER M
TEULON JM
VERSIGNY A
CAZES M
VIRONEODDOS A
CAUSSADE F
CLOAREC A
Citation: E. Nicolai et al., SYNTHESIS AND ANGIOTENSIN-II RECEPTOR ANTAGONIST ACTIVITY OF C-LINKEDPYRAZOLE DERIVATIVES, Chemical and Pharmaceutical Bulletin, 42(8), 1994, pp. 1617-1630